74 results
424B3
COSM
Cosmos Health Inc
29 Feb 24
Prospectus supplement
4:33pm
subsidiaries in Greece and UK serving retail pharmacies and wholesale distributors. Cosmos Health is strategically focused on the research and development … and general corporate purposes, which may include operating expenses, research and development, and funding for pending or future acquisitions. We will set
8-K
EX-99.1
COSM
Cosmos Health Inc
10 Oct 23
COSMOS HEALTH CEO Issues Letter to Shareholders
4:05pm
acquisitions, growing our brands globally, advancing our research and development (R&D) projects, investing in our facilities, securing critical real
424B3
COSM
Cosmos Health Inc
31 Aug 23
Prospectus supplement
5:27pm
. The Company is strategically focused on the research and development (“R&D”) of novel patented nutraceuticals and specialized root extracts, as well
424B5
89nlpx8
21 Jul 23
Prospectus supplement for primary offering
11:26am
8-K
EX-10.1
us91n
11 May 23
Entry into a Material Definitive Agreement
9:11am
424B5
nz8g j06xjl
21 Dec 22
Prospectus supplement for primary offering
2:46pm
424B3
xurxdp5udt yzmn3obm9
20 Dec 22
Prospectus supplement
8:27am
DEF 14A
bsi7tn7
20 Oct 22
Definitive proxy
4:51pm
424B3
ngq jpnz24enc2
19 Oct 22
Prospectus supplement
7:01pm